FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joost Sluijter

Research Profile

Anatomy

Procedures

Living Beings

Mouse

Chemicals & Drugs

Physiology

Disorders

Myocardial Infarction

Co-author Network

Publications

TOP 3
Martinus I F J Oerlemans; Steven A J Chamuleau; Dominique P de Kleijn; Pieter A Doevendans; Stefan Koudstaal; Joost P G Sluijter
Targeting cell death in the reperfused heart: Pharmacological approaches for cardioprotection.
Derek J Hausenloy; Gerd Heusch; Sandrine Lecour; Rosalinda Madonna; Gianluigi Condorelli; Hans Erik Bøtker; Peter Ferdinandy; David Garcia-Dorado; Marisol Ruiz-Meana; Rainer Schulz; Joost P G Sluijter; Linda W van Laake; Derek M Yellon; Michel Ovize
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
Fatih Arslan; Brigitta Buttari; Lars Akeroyd; Krista den Ouden; Emrah Kara; Sai-Kiang Lim; Gerard Pasterkamp; Elisabetta Profumo; Rachele Riganò; Joost P G Sluijter; Mirjam B Smeets; Leo Timmers; Ben J Van Middelaar; Dominique P V de Kleijn
Lack of haptoglobin results in unbalanced VEGFα/angiopoietin-1 expression, intramural hemorrhage and impaired wound healing after myocardial infarction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joost Sluijter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martinus I F J Oerlemans; Steven A J Chamuleau; Dominique P de Kleijn; Pieter A Doevendans; Stefan Koudstaal; Joost P G Sluijter
Targeting cell death in the reperfused heart: Pharmacological approaches for cardioprotection.
International journal of cardiology 2013;165(3):410-22.
2013: Derek J Hausenloy; Gerd Heusch; Sandrine Lecour; Rosalinda Madonna; Gianluigi Condorelli; Hans Erik Bøtker; Peter Ferdinandy; David Garcia-Dorado; Marisol Ruiz-Meana; Rainer Schulz; Joost P G Sluijter; Linda W van Laake; Derek M Yellon; Michel Ovize
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
Cardiovascular research 2013;98(1):7-27.
2013: Fatih Arslan; Brigitta Buttari; Lars Akeroyd; Krista den Ouden; Emrah Kara; Sai-Kiang Lim; Gerard Pasterkamp; Elisabetta Profumo; Rachele Riganò; Joost P G Sluijter; Mirjam B Smeets; Leo Timmers; Ben J Van Middelaar; Dominique P V de Kleijn
Lack of haptoglobin results in unbalanced VEGFα/angiopoietin-1 expression, intramural hemorrhage and impaired wound healing after myocardial infarction.
Journal of molecular and cellular cardiology 2013;56():116-28.
2012: Junjie Xiao; Dasheng Zhang; Hong Zhang; Xiaoli Chen; Pieter A Doevendans; Dandan Liang; Xingqun Liang; Ying Liu; Yi Liu; Lei Pan; Joost P G Sluijter; Yunfu Sun; Yi-Han Chen
MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells.
Journal of molecular and cellular cardiology 2012;53(6):751-9.
2012: Martinus I F J Oerlemans; Gerard Pasterkamp; Alain van Mil; Evelyn A de Vrey; Marieke S Dekker; Pieter A Doevendans; Arno W Hoes; Arend Mosterd; Joost P G Sluijter
Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs.
EMBO molecular medicine 2012;4(11):1176-85.
2012: Tycho I G van der Spoel; Krijn R Vrijsen; Maarten-Jan M Cramer; Hugo W de Jong; Pieter A Doevendans; Imo E Hoefer; Stefan Koudstaal; Johannes F W Nijsen; Joost P G Sluijter; Eric van Belle; Steven A J Chamuleau
Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency.
Journal of cellular and molecular medicine 2012;16(11):2768-76.
2012: Frebus J van Slochteren; Maarten J M Cramer; Pieter A Doevendans; Stefan Koudstaal; Joost P G Sluijter; Arco J Teske; Tycho I G van der Spoel; Steven A J Chamuleau
Advanced measurement techniques of regional myocardial function to assess the effects of cardiac regenerative therapy in different models of ischaemic cardiomyopathy.
European heart journal cardiovascular Imaging 2012;13(10):808-18.
2012: Jia Liu; Corina Metz; Sailay Siddiqi; Gustav J Strijkers; Alain van Mil; Krijn Vrijsen; Jiajun Zhao; Eissa N E Aguor; Pieter A Doevendans; Sridevi Jaksani; Joost P G Sluijter
MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16.
Journal of cellular and molecular medicine 2012;16(10):2379-86.
2012: Patrick van Vliet; Pieter A Doevendans; Marie-José Goumans; Joost P G Sluijter
Human cardiomyocyte progenitor cells: a short history of nearly everything.
Journal of cellular and molecular medicine 2012;16(8):1669-73.
2012: Willy A Noort; M I F J Oerlemans; Henk Rozemuller; H J Bühring; Pieter A Doevendans; D Feyen; S Jaksani; Anton Martens; B Naaijkens; D Stecher; Joost P G Sluijter
Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation.
Journal of cellular and molecular medicine 2012;16(8):1827-39.
2012: Martinus I F J Oerlemans; Ben J Van Middelaar; Fatih Arslan; Krista den Ouden; Pieter A Doevendans; Jia Liu; Joost P G Sluijter
Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
Basic research in cardiology 2012;107(4):270.
2012: Paul W Riem Vis; Joost P G Sluijter; R Sarita Soekhradj-Soechit; Lex A van Herwerden; Jolanda Kluin; Carlijn V C Bouten
Sequential use of human-derived medium supplements favours cardiovascular tissue engineering.
Journal of cellular and molecular medicine 2012;16(4):730-9.
2012: Alain van Mil; Pieter A Doevendans; Marie-José Goumans; Sebastian Grundmann; Sridevi Jaksani; Zhiyong Lei; Martinus I Oerlemans; Joost P G Sluijter
MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release.
Cardiovascular research 2012;93(4):655-65.
2011: Tycho I G van der Spoel; Pierfrancesco Agostoni; Maarten J Cramer; Pieter A Doevendans; Mariann Gyöngyösi; Sanne J Jansen of Lorkeers; Joost P G Sluijter; Eric van Belle; Steven A J Chamuleau
Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease.
Cardiovascular research 2011;91(4):649-58.
2011: Jia Liu; Corina H G Metz; Pieter A Doevendans; Ling Gao; Marie-José Goumans; Alain van Mil; Krijn Vrijsen; Jiajun Zhao; Joost P G Sluijter
MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1.
Journal of cellular and molecular medicine 2011;15(7):1474-82.
2011: Daphne van Geemen; Sarita Soekhradj-Soechit; Joost P G Sluijter; Jolanda Kluin; Moniek de Liefde-van Beest; Paul W Riem Vis; Carlijn V C Bouten
Decreased mechanical properties of heart valve tissue constructs cultured in platelet lysate as compared to fetal bovine serum.
Tissue engineering. Part C, Methods 2011;17(5):607-17.
2011: Sebastian Grundmann; Felix P Hans; Sheena Kinniry; Jennifer Heinke; Thomas Helbing; Franziska Bluhm; Joost P G Sluijter; Imo Hoefer; Gerard Pasterkamp; Christoph Bode; Martin Moser
MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells.
Circulation 2011;123(9):999-1009.
2011: Tycho I G van der Spoel; Joe Chun-Tsu Lee; Krijn Vrijsen; Joost P G Sluijter; Maarten-Jan M Cramer; Pieter A Doevendans; Eric van Belle; Steven A J Chamuleau
Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium.
The international journal of cardiovascular imaging 2011;27(3):367-83.
2011: Bernard C te Boekhorst; Sandra M Bovens; Willem E Hellings; Petra H van der Kraak; Kees W van de Kolk; Aryan Vink; Frans L Moll; Matthijs F M van Oosterhout; Jean-Paul P M de Vries; Pieter A Doevendans; Marie-José Goumans; Dominique P V de Kleijn; Cees J A van Echteld; Gerard Pasterkamp; Joost P G Sluijter
Molecular MRI of murine atherosclerotic plaque targeting NGAL: a protein associated with unstable human plaque characteristics.
Cardiovascular research 2011;89(3):680-8.
2011: Paul W Riem Vis; Jolanda Kluin; Joost P G Sluijter; Lex van herwerden; Carlijn V C Bouten
Environmental regulation of valvulogenesis: implications for tissue engineering.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2011;39(1):8-17.
2010: Martinus I F J Oerlemans; Marie-José Goumans; Ben van Middelaar; Hans Clevers; Pieter A Doevendans; Joost P G Sluijter
Active Wnt signaling in response to cardiac injury.
Basic research in cardiology 2010;105(5):631-41.
2010: Patrick van Vliet; Teun P de Boer; Marcel A G van der Heyden; Mazen K El Tamer; Joost P G Sluijter; Pieter A Doevendans; Marie-José Goumans
Hyperpolarization induces differentiation in human cardiomyocyte progenitor cells.
Stem cell reviews 2010;6(2):178-85.
2010: Roberto Gaetani; Giuseppe Rizzitelli; Isotta Chimenti; Lucio Barile; Elvira Forte; Vittoria Ionta; Francesco Angelini; Joost P G Sluijter; Andrea Barbetta; Elisa Messina; Giacomo Frati
Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application.
Journal of cellular and molecular medicine 2010;14(5):1071-7.
2010: K R Vrijsen; Joost P G Sluijter; M W L Schuchardt; B W M van Balkom; Willy A Noort; S A J Chamuleau; Pieter A Doevendans
Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells.
Journal of cellular and molecular medicine 2010;14(5):1064-70.
2010: Patrick van Vliet; Anke M Smits; Teun P de Boer; Tom H Korfage; Corina H G Metz; Marta Roccio; Marcel A G van der Heyden; Toon A B van Veen; Joost P G Sluijter; Pieter A Doevendans; Marie-José Goumans
Foetal and adult cardiomyocyte progenitor cells have different developmental potential.
Journal of cellular and molecular medicine 2010;14(4):861-70.
2010: Joost P G Sluijter; Alain van Mil; Patrick van Vliet; Corina H G Metz; Jia Liu; Pieter A Doevendans; Marie-José Goumans
MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(4):859-68.
2010: Paul W Riem Vis; Carlijn V C Bouten; Joost P G Sluijter; Gerard Pasterkamp; Lex A van Herwerden; Jolanda Kluin
Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering.
Tissue engineering. Part A 2010;16(4):1317-27.
2010: Simone Post; Anke M Smits; Alexandra J van den Broek; Joost P G Sluijter; Imo E Hoefer; Ben J Janssen; Repke J Snijder; Johannes J Mager; Gerard Pasterkamp; Christine L Mummery; Pieter A Doevendans; Marie-José Goumans
Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance.
Cardiovascular research 2010;85(3):494-502.
2010: Teun P de Boer; Toon A B van Veen; Malin Jonsson; Bart G J M Kok; Corina H G Metz; Joost P G Sluijter; Pieter A Doevendans; Jacques M T de Bakker; Marie-José Goumans; Michiel van der Heyden
Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype.
Journal of molecular and cellular cardiology 2010;48(1):254-60.
2009: K R Vrijsen; S A J Chamuleau; Willy A Noort; Pieter A Doevendans; Joost P G Sluijter
Stem cell therapy for end-stage heart failure: indispensable role for the cell?
Current opinion in organ transplantation 2009;14(5):560-5.
2009: Willy A Noort; Joost P G Sluijter; Marie-José Goumans; Steven A J Chamuleau; Pieter A Doevendans
Stem cells from in- or outside of the heart: isolation, characterization, and potential for myocardial tissue regeneration.
Pediatric cardiology 2009;30(5):699-709.
2009: Jia Liu; Joost P G Sluijter; Marie-Jose Goumans; Anke M Smits; Tycho van der Spoel; Hendrik Nathoe; Pieter A Doevendans
Cell therapy for myocardial regeneration.
Current molecular medicine 2009;9(3):287-98.
2009: Alain van Mil; Pieter A Doevendans; Joost P G Sluijter
The potential of modulating small RNA activity in vivo.
Mini reviews in medicinal chemistry 2009;9(2):235-48.
2009: Pieter T G Bot; Imo E Hoefer; Joost P G Sluijter; Patrick van Vliet; Anke M Smits; Franck Lebrin; Frans Moll; Jean-Paul de Vries; Pieter A Doevendans; Jan J Piek; Gerard Pasterkamp; Marie-José Goumans
Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques.
Stroke; a journal of cerebral circulation 2009;40(2):439-47.
2009: Anke M Smits; Patrick van Vliet; Corina H Metz; Tom Korfage; Joost P G Sluijter; Pieter A Doevendans; Marie-José Goumans
Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology.
Nature protocols 2009;4(2):232-43.
2008: P van Vliet; Marta Roccio; A M Smits; A A M van Oorschot; C H G Metz; T A B van Veen; Joost P G Sluijter; Pieter A Doevendans; Marie-José Goumans
Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(5):163-9.
2008: Arjan H Schoneveld; Imo E Hoefer; Joost P G Sluijter; J D Laman; Dominique P V de Kleijn; Gerard Pasterkamp
Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness.
Atherosclerosis 2008;197(1):95-104.
2008: Leo Timmers; Joost P G Sluijter; J Karlijn Van Keulen; Imo E Hoefer; Marcel G J Nederhoff; Marie-José Goumans; Pieter A Doevendans; Cees J A van Echteld; Jaap A Joles; Paul H A Quax; Jan J Piek; Gerard Pasterkamp; Dominique P V de Kleijn
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
Circulation research 2008;102(2):257-64.
2008: Simone Post; Wouter Peeters; Els Busser; Dennis Lamers; Joost P G Sluijter; Marie-José Goumans; Roel A de Weger; Frans L Moll; Pieter A Doevendans; Gerard Pasterkamp; Aryan Vink
Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density.
Journal of vascular research 2008;45(3):244-50.
2007: Marie-José Goumans; Teun de Boer; Anke M Smits; Linda W van Laake; Patrick van Vliet; Corina H G Metz; Tom H Korfage; K Peter Kats; Ron Hochstenbach; Gerard Pasterkamp; Marianne C Verhaar; Marcel A G van der Heyden; Dominique P V de Kleijn; Christine L Mummery; Toon A B van Veen; Joost P G Sluijter; Pieter A Doevendans
TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro.
Stem cell research 2007;1(2):138-49.
2007: Leo Timmers; Joost P G Sluijter; Cees W J Verlaan; Paul Steendijk; Maarten-Jan M Cramer; Maringa Emons; Chaylendra Strijder; Paul F Gründeman; Siu Kwan Sze; Lin Hua; Jan J Piek; Cornelius Borst; Gerard Pasterkamp; Dominique P V de Kleijn
Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.
Circulation 2007;115(3):326-32.
2007: Patrick van Vliet; Joost P G Sluijter; Pieter A Doevendans; Marie-José Goumans
Isolation and expansion of resident cardiac progenitor cells.
Expert review of cardiovascular therapy 2007;5(1):33-43.
2006: Joost P G Sluijter; Dominique P V de Kleijn; Gerard Pasterkamp
Vascular remodeling and protease inhibition--bench to bedside.
Cardiovascular research 2006;69(3):595-603.
2006: Joost P G Sluijter; Wilco P C Pulskens; Arjan H Schoneveld; Evelyn Velema; Chaylendra Strijder; Frans Moll; Jean-Paul P M de Vries; Jan H Verheijen; roeland hanemaaijer; Dominique P V de Kleijn; Gerard Pasterkamp
Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms.
Stroke; a journal of cerebral circulation 2006;37(1):235-9.
2005: Joost P G Sluijter; Robert E Verloop; Wilco P C Pulskens; Evelyn Velema; Jos M Grimbergen; Paul H A Quax; Marie-José Goumans; Gerard Pasterkamp; Dominique P V de Kleijn
Involvement of furin-like proprotein convertases in the arterial response to injury.
Cardiovascular research 2005;68(1):136-43.
2005: Juan A Rodriguez-Feo; Joost P G Sluijter; Dominique P V de Kleijn; Gerard Pasterkamp
Modulation of collagen turnover in cardiovascular disease.
Current pharmaceutical design 2005;11(19):2501-14.
2004: Joost P G Sluijter; Mirjam B Smeets; Evelyn Velema; Gerard Pasterkamp; Dominique P V de Kleijn
Increase in collagen turnover but not in collagen fiber content is associated with flow-induced arterial remodeling.
Journal of vascular research 2004;41(6):546-55.
2004: Joost P G Sluijter; Mirjam B Smeets; Evelyn Velema; Gerard Pasterkamp; Dominique P V de Kleijn
Increased collagen turnover is only partly associated with collagen fiber deposition in the arterial response to injury.
Cardiovascular research 2004;61(1):186-95.
2003: Mirjam B Smeets; Joost P G Sluijter; Marjo M P C Donners; Evelyn Velema; Sylvia Heeneman; Gerard Pasterkamp; Dominique P V de Kleijn
Increased arterial expression of a glycosylated haptoglobin isoform after balloon dilation.
Cardiovascular research 2003;58(3):689-95.
2002: Aryan Vink; Arjan H Schoneveld; Jelger J van der Meer; Ben J Van Middelaar; Joost P G Sluijter; Mirjam B Smeets; Paul H A Quax; Sai-Kiang Lim; Cornelius Borst; Gerard Pasterkamp; Dominique P V de Kleijn
In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions.
Circulation 2002;106(15):1985-90.
2001: Dominique P V de Kleijn; Joost P G Sluijter; J Smit; Evelyn Velema; W Richard; Arjan H Schoneveld; Gerard Pasterkamp; Cornelius Borst
Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling.
FEBS letters 2001;501(1):37-41.